Gait and Muscle Power Training for Children With Developmental Coordination Disorder

February 8, 2019 updated by: Shirley S.M. Fong, The University of Hong Kong

Rhythmical Auditory Stimulation Gait Training and Muscle Power Training for Primary School Children With Developmental Coordination Disorder: A Randomized Controlled Trial

Objectives: To compare the effectiveness of RAS-MPT, RAS alone, MPT alone, and usual care (as a control) for improving the overall gait performance of and reducing falls in children with developmental coordination disorder (DCD) and to explore the relationship between gait performance and falls in this population.

Design: A randomized controlled trial. Sample: 76 children with DCD. Interventions: RAS-MPT, RAS alone, MPT alone, or usual care (12 weeks). Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and a 6-month follow-up. Comprehensive gait analysis will produce spatiotemporal gait parameters (e.g., velocity and stride length), kinematic gait parameters (e.g., knee joint motions), and leg muscle EMG outcomes; an isokinetic test will quantify leg muscle strength and force production time; and fall histories will be obtained via interviews. Anticipated results and significance: The RAS-MPT group is predicted to display the best gait performance, which is associated with reduced fall incidents. This novel training regime can be readily adopted in school, clinical, or home settings to improve locomotor ability in children with DCD, an outcome with positive socioeconomic implications.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Shirley Fong, PhD
  • Phone Number: 28315260
  • Email: smfong@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 9 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 6 to 9 years old
  • classified as DCD according to the Diagnostic and Statistical Manual of Mental Disorders V
  • < 5th percentile on the Movement Assessment Battery for Children-2 (MABC-2)
  • a total score of < 46 (for children aged 6 to 7 years 11 months) or < 55 (for children aged 8 to 9 years) on the DCD questionnaire 2007 (Chinese version)
  • attending a mainstream school (i.e., intelligence level within the normal range).

Exclusion Criteria:

  • any congenital, cognitive, psychiatric (e.g., comorbid attention deficit hyperactivity disorder or autism spectrum disorder), neurological, sensory, hearing, visual, vestibular, musculoskeletal, or cardiopulmonary disorder that may affect test performance
  • obesity (body mass index [BMI] >95th percentile)
  • receiving active treatment such as physiotherapy
  • those unable to follow instructions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RAS-MPT group
Rhythmical auditory stimulation gait training and muscle power training group
The RAS-MPT group will attend a 60-minute training session once a week and home exercises (twice/week) for 12 weeks. Participants will receive two levels of training within each 60-minute session: (1) RAS-treadmill training and (2) MPT.
Experimental: RAS group
Rhythmical auditory stimulation gait training group
The RAS group will attend a 60-minute training session once a week and home exercises (twice/week) for 12 weeks. Participants will receive RAS-treadmill training repeatedly within each 60-minute session.
Experimental: MPT group
Muscle power training group
The MPT group will attend a 60-minute training session once a week and home exercises (twice/week) for 12 weeks. Participants will receive muscle power training repeatedly within each 60-minute session.
Other: Control group
Usual care group
Participants in the control group will receive no intervention during the study period, but continue with their normal daily activities and usual medical care. They will receive the same training as the RAS-MPT group after the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in spatiotemporal gait parameter - gait velocity (m/s)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - stride length (cm)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - cadence (steps/min)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - stance phase duration (% gait cycle)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - swing phase duration (% gait cycle)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - single-limb support durations (% gait cycle)
Time Frame: 9 months
9 months
Changes in spatiotemporal gait parameter - double-limb support duration (% gait cycle)
Time Frame: 9 months
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in kinematic gait parameters
Time Frame: 9 months
Maximum knee and ankle angles during different gait phases
9 months
Changes in leg muscle peak electromyographic values
Time Frame: 9 months
Changes in leg muscle peak electromyographic values (in % of maximal voluntary isometric contraction) of rectus femoris, biceps femoris, tibialis anterior, and gastrocnemius medialis muscles
9 months
Changes in leg muscle maximum strength
Time Frame: 9 months
Changes in maximum muscle strength of knee extensors and flexors and ankle plantar flexors and dorsiflexors of the dominant leg as measured by dynamometry.
9 months
Changes in leg muscle force production time
Time Frame: 9 months
Changes in muscle force production time of knee extensors and flexors and ankle plantar flexors and dorsiflexors of the dominant leg as measured by dynamometry.
9 months
Changes in self-reported falls
Time Frame: 9 months
Children and parents will report the number of falls within the study period.
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2019

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

February 6, 2019

First Submitted That Met QC Criteria

February 8, 2019

First Posted (Actual)

February 12, 2019

Study Record Updates

Last Update Posted (Actual)

February 12, 2019

Last Update Submitted That Met QC Criteria

February 8, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 001 (NavyGHB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Developmental Coordination Disorder

Clinical Trials on Rhythmical auditory stimulation gait training and muscle power training (RAS-MPT)

3
Subscribe